Atrial Appendage Occluder Market Segment Overview, Analysis and Forecast to 2032

The Atrial Appendage Occluder Market size was worth US$ 854.6 million in 2022 and is expected to rise at a staggering double-digit CAGR of 23.95% to reach US$ 7,316.9 million by the end of the forecast year (2022 to 2032).

The left atrial appendage (LAA), also known as the atrial appendage, is an ear-shaped pouch situated in the upper left chamber of the human heart, the left atrium. Regardless of its structure, the function of LAA is unknown. Individuals with arrhythmic cardiovascular diseases, such as atrial fibrillation, may have blood accumulation in the LAA, resulting in the production of blood clots that, if they enter the bloodstream, can cause deadly strokes.

Atrial Appendage Occluder Market: Drivers and Restraints

The increased number of cardiovascular patients diagnosed with thromboembolism and atrial fibrillation worldwide is driving the global market for Atrial Appendage Occluders. Sedentary lifestyles and accompanying diseases such as diabetes, obesity, and hypertension have further increased demand for such devices, paving the way for market expansion.

However, the restricted usage of LAA occluders in patients at high risk of stroke and bleeding while on anticoagulant medication may limit market expansion. Furthermore, the implantation and removal of the device can result in complications such as tissue erosion, which may necessitate open-heart surgery, restricting market growth. Furthermore, unfavourable laws governing endocardial LAA closure have stifled industry expansion.

Atrial Appendage Occluder Market: Region-wise Outlook

North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and the Middle East and Africa are the geographical segments of the Atrial Appendage Occluder Market. The North American market now leads the global industry, owing mostly to its vast elderly population.

Atrial Appendage Occluder Market: Key Players

The key players in the global Atrial Appendage Occluder Market include Appriva Medical Inc., Boston Scientific, St. Jude Medical, SentreHEART Inc, pfm medical ag., Occlutech, W. L. Gore Associates, Inc., Cardia, Inc. and AtriCure, Inc.

Get Detail Summary@ https://www.futuremarketinsights.com/reports/atrial-appendage-occluder-market

Key Segments Profiled In The Atrial Appendage Occluder Industry Survey

Type of indication: